GHK CU Apollo Peptide Sciences The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier An important update for anyone following the peptide space. While these compounds are still under evaluation and not FDA approved, this shift signals growing momentum toward clinician guided peptide research. Stay informed, stay The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York GHK Cu Topical Spray Wells Pharmacy Network